LOUISVILLE, Ky., Nov. 6, 2025 /PRNewswire/ — Master Distiller Dan McKee and Master of Maturation Andrea Wilson have approved the release of Michter’s 20 Year Kentucky Straight Bourbon. Shipments of this rare whiskey to bars, restaurants, and stores will begin December 1st. This release comes three months after Michter’s was named The World’s Most Admired Whiskey for an unprecedented third time. In August, Drinks International published the 2025 list of the World’s Most Admired Whiskies. The rankings are determined by an international academy consisting of 100 independent global drinks buyers, journalists, bartenders and whisky experts, and it includes legendary distillers from Scotland, Japan, Ireland, and beyond.

The 2025 Relase of Michter’s 20 Year Bourbon

“By law bourbon must be aged in a brand new barrel, which imparts flavor, color and oak character more quickly than a used barrel. To age a whiskey that will taste wonderful after two decades in a first-use barrel is an extremely difficult endeavor that requires a skillful balance of art and science. I believe that people will appreciate the thoughtful and conscientious work of our production team when they taste this exceptional whiskey,” commented Michter’s President Joseph J. Magliocco.

Barrel management and precisely controlled warehouse conditions are critical to the quality of aged whiskey. Master of Maturation Andrea Wilson oversees both of these important areas for Michter’s. Wilson observed, “Details matter when it comes to aging bourbon gracefully. Michter’s 20 Year Bourbon is an exemplary representation of how oak can be used to deepen vanilla, toffee, chocolate, spice, fruit, and confectionery notes that enhance complexity in bourbon. We hope that everyone who gets the opportunity to taste this product is able to experience the beloved attributes of a beautiful, timeless bourbon crafted through intentional aging.”

The proof of this 2025 release is 114.2 (57.1% ABV), and the suggested U.S. retail price is $1,200 for a 750ml bottle.

“Our production team takes great pride in offering such a special whiskey. A lot of time and effort goes into maturing these barrels so that they are extraordinary for this release,” said Master Distiller Dan McKee.

Beyond its main distillery in the Shively section of Louisville, Michter’s operations extend to two other sites in Kentucky. In Springfield, Michter’s is farming estate grown grain on its 205-acre property, while in downtown Louisville, Michter’s has its second distillery in the historic Fort Nelson Building. Situated in a prime location on West Main Street opposite Louisville Slugger and on the same block as the Frazier Museum, Michter’s Fort Nelson Distillery features the legendary pot still system from Michter’s Pennsylvania. It also has educational tours with whiskey tastings and The Bar at Fort Nelson, which features classic cocktails curated by spirits and cocktail historian David Wondrich.

Michter’s has a rich and long legacy of offering traditional American whiskeys of uncompromising quality. With each of its limited production offerings aged to its peak maturity, Michter’s highly acclaimed portfolio includes bourbon, rye, sour mash whiskey, and American whiskey. For more information about Michter’s, please visit michters.com and follow us on Instagram, Facebook, and X.

Contact:
Joseph J. Magliocco
+1 (502) 774-2300 x580
jmagliocco@michters.com

– Strategic investment enhances service to North American customers and supports rising market demand for high-quality ingredients –

BASEL, Switzerland, Nov. 6, 2025 /PRNewswire/ — Jungbunzlauer, a global leader in high-quality ingredients from natural sources, today announced the successful closing of its acquisition of the production site in Thomson, Illinois from International Flavors & Fragrances, Inc. (IFF). 

This milestone marks Jungbunzlauer’s first U.S. manufacturing facility, enhancing its ability to serve North American customers with greater proximity and responsiveness.

The Thomson site will be developed to support Jungbunzlauer’s portfolio of naturally derived ingredients, with preparations, equipment installation, and regulatory compliance activities commencing immediately. 

The company, well known for its high-quality citric acid, develops and manufactures a wide product portfolio including mineral salts, texturants and acidulants. Together with the recent expansion of its biogums facility in Canada, this acquisition positions Jungbunzlauer to meet growing demand and deliver high-quality solutions across North America. 

“This acquisition is a significant step in Jungbunzlauer’s growth journey. We are proud to establish our first U.S. manufacturing facility in Thomson, Illinois, and look forward to delivering sustainable, trusted solutions for our customers. We plan to invest in advanced manufacturing and deliver long-term value for the region, our customers and stakeholders,” said Bruno Tremblay, Chief Executive Officer, Jungbunzlauer. 

Jungbunzlauer is committed to being an active partner in the Thomson community. By localising production, the company aims to create jobs, support local suppliers, and contribute to regional economic growth. Its approach emphasises efficient operations and responsible sourcing, reflecting a dedication to customer needs and community support. 

“Jungbunzlauer’s reputation for responsible, quality manufacturing makes them an ideal addition to the Illinois business community. We are proud to welcome them to Thomson and look forward to supporting their growth, which will bring new, high-quality opportunities for our workforce, suppliers, and the region,” said David Schmit, Regional Director, Northwest Illinois Economic Development. 

The asset deal does not include any of IFF’s commercial business, product lines, or employees. 

“We look forward to providing further updates, including operational plans, future hiring, and community engagement initiatives as we prepare the facility for production,” concluded Mr Tremblay. 

About Jungbunzlauer

Jungbunzlauer is a leading producer of high-quality, sustainable ingredients from natural sources, serving industries from food and beverage, to nutrition, health, home and personal care, among others. Leading the way in developing naturally better ingredients that enhance everyday life, we are a trusted partner offering a diverse portfolio of texturants, acidulants, sweeteners, minerals, and tailored solutions to meet our customers’ evolving needs.

Headquartered in Basel, Switzerland, with state-of-the-art facilities including large-scale fermentation operations across Europe and North America, we proudly serve more than 130 countries worldwide. Founded more than 150 years ago, Jungbunzlauer has grown into a CHF 1.3 billion company, driven by nearly 1,400 dedicated colleagues committed to a healthier, more sustainable future. Learn more at www.jungbunzlauer.com.

Recognition Highlights the Company’s Breakthrough in Autonomous Vision AI for Digital Automation

SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ — INFOFLA, a rising leader in autonomous AI solutions, today announced that its flagship product, Selto, the vision-based autonomous AI agent, has been named a CES 2026 Innovation Award Honoree for outstanding achievement in technology and design.

Hosted by the Consumer Technology Association (CTA), the CES Innovation Awards recognize cutting-edge innovations shaping the future of global industries. This honor positions INFOFLA among the world’s most forward-thinking companies advancing next-generation intelligent automation.

Selto introduces a new paradigm in digital work automation.

Unlike traditional RPA tools or text-based AI agents, Selto “sees” and interacts with user interfaces visually—identifying buttons, menus, and forms just as a human would. Powered by advanced Vision-Language Models (VLMs) and adaptive learning architecture, Selto autonomously performs complex, end-to-end tasks without requiring scripts, APIs, or system integration.

This breakthrough enables organizations to automate workflows across even the most complex or restricted systems, including public service portals, legacy applications, and secure enterprise software. Selto delivers human-level perception, real-time adaptability, and enhanced scalability, making it a transformative solution for enterprise digital transformation.

INFOFLA’s innovation has already gained significant international momentum. In late October, the company showcased Selto at TechCrunch Disrupt San Francisco 2025, forming strategic partnerships with technology distributors and enterprise buyers across North America. To accelerate global expansion, INFOFLA is now establishing a U.S. subsidiary and plans to increase R&D collaboration and enterprise deployments worldwide.

“Selto was designed to bridge the gap between human understanding and digital execution,” said Inmook Choi, CEO of INFOFLA. “Winning the CES 2026 Innovation Award is a meaningful milestone that validates our mission to redefine what is possible with intelligent, vision-driven automation.”

By removing traditional technical barriers and supporting secure, on-premise-compatible deployment, INFOFLA is setting a new global benchmark for intelligent automation in the AI era.

About INFOFLA

INFOFLA is a South Korea–based AI technology company specializing in vision-based autonomous AI agents that empower organizations to automate any digital task—without code, APIs, or system integration. With a focus on inclusivity, adaptability, and security, INFOFLA empowers industries to adopt AI-driven automation that mirrors human decision-making and accelerates digital transformation.

For more information, visit www.infofla.com or linkedin.com/company/infofla.

NEW YORK, Nov. 6, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on November 6th

• Stocks are little changed Thursday morning after they rebounded on Wednesday, lifted by a surge in AI-related names. This included NYSE-listed Oracle, which ended the day up nearly 1%.
• Evommune will go public on the NYSE today. The biotech priced at $16 a share after raising $150 million. The company specializes in treating chronic inflammatory diseases such as Eczema and Hives.
• Grupo Aeromexico will also celebrate its IPO today. The IPO priced at $19 a share after raising $223 million. The Mexico-based airline provides service that connects Mexico with the rest of the world.
• NYSE-listed Altice USA will change its name to Optimum Communications beginning tomorrow. The company will also change its ticker symbol to OPTU beginning on Wednesday, November 19th.

Opening Bell
Evommune (NYSE: EVMN) celebrates its IPO

Closing Bell
Arrow Electronics (NYSE: ARW) marks its 90^th anniversary of founding

Click here to download the NYSE TV App

Video – https://mma.prnasia.com/media2/2815908/NYSE_Nov_6_Market_Update.mp4 

TOKYO, Nov. 6, 2025 /PRNewswire/ — Carrier Japan’s air-cooled modular chiller / heat pump Universal Smart X (USX) series has been included in the EXPO 2025 Special Edition of the Green Technology Book. Published by World Intellectual Property Organization (WIPO), the prestigious recognition was unveiled at EXPO 2025 Osaka, showcasing over 200 impactful energy innovations from the Asia Pacific region and highlighting technologies that contribute to a more sustainable future. Carrier Japan is a part of Carrier Global Corporation (NYSE: CARR), global leader in intelligent climate and energy solutions.

“Being featured in WIPO’s Green Technology Book reflects the strength of the USX series, not only as a technological innovation, but as a solution that meets the evolving needs of our planet as well as our customers,” said Toru Kubo, President, Carrier Japan. “This recognition reinforces our commitment to sustainability and our mission to deliver energy-efficient solutions. We will continue to listen to our customers and innovate with purpose, ensuring our technologies contribute to the world we share.”

As part of the United Nations, WIPO plays a vital role in supporting global innovation by ensuring that intellectual property rights are protected and that transformative ideas reach the market. WIPO’s Green Technology Book focuses on energy solutions in the Asia Pacific region – the fastest growing region in the world and home to 60% of the global population.

The USX series, a leading modular chiller and heat pump series in Japan, has earned multiple accolades for innovation and energy efficiency. The USX EDGE 32, a popular solution for data centers and other commercial and industrial applications including factories, received the highest honor at the 2021 Energy Conservation Grand Prize Awards Japan. Concurrently, the USX FIT, recognized for its triplet rotary compressors, space-saving design and retrofit capability, was awarded the top prize at the 2025 Demand Side Management Awards Japan. Its recent inclusion in the Green Technology Book adds another distinguished recognition to its celebrated legacy and underscores Carrier Japan’s commitment to advancing energy-efficient solutions and supporting global efforts toward a more sustainable future.

About Carrier Japan
Carrier Japan provides sustainable solutions integrating energy efficient products for residential, light commercial and industrial customers. Carrier Japan is a part of Carrier Global Corporation (NYSE: CARR), global leader in intelligent climate and energy solutions, committed to creating innovations that bring comfort, safety and sustainability to life. For more information, visit Carrier HVAC Asia Pacific.

Carrier. For the World We Share.

Contact:  
Mikiko Kato
mikiko.katou1@carrier.com
Media Relations
Carrier Japan Corporation

BELLEVUE, Wash., Nov. 6, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH) today announced the key findings from a company-sponsored pilot study conducted by Woori IO, an OSR Company, in collaboration with Korea University Guro Hospital. The study, which took place from May 9 to September 12, 2023, evaluated the performance of the Glucheck blood glucose measurement system and validated its accuracy, stability, and usability across a representative participant group.

Although the Clinical Study Report (CSR) for this exploratory trial was completed in 2023, Woori IO, then a private R&D-stage company, had no obligation for public disclosure. Now, as part of the publicly listed OSRH healthcare group, the company is pleased to share these results based on the CSR authored by Dr. Soo-Young Yoon, Department of Laboratory Medicine, Korea University Guro Hospital. OSRH believes the findings represent a significant technical milestone for a first-in-class, noninvasive glucose monitoring technology.

Study Overview and Results

The Glucheck system, available in mouse-type (WH-G23031) and stick-type (WH-G23041) models, was tested against the AU5800 Chemistry Analyzer by Beckman Coulter as a baseline reference device. The study enrolled 145 participants, with 140 datasets used for calibration and validation. Key findings, based on the value manually selected from those derived from three analytical formulas, showed:

High Accuracy: Over 90% of measurements across both device models achieved ≥85% accuracy, with fewer than 8% falling below 74%. Accuracy by blood glucose range as follows:

50–99 mg/dL: Over 85% of all measurements showed ≥85% accuracy, while <8% were below 74%.

100–149 mg/dL: Over 97% of all measurements showed ≥85% accuracy, with none below 74%.

150–199 mg/dL: Over 87% of all measurements showed ≥85% accuracy, while <13% were below 74%.

200–249 mg/dL: 100% of all measurements showed ≥85% accuracy.

• Strong Precision: Repeatability was confirmed within a 5% coefficient of variation (CV), demonstrating stable performance.
• Robust Correlation: Correlation coefficients (r) exceeded 0.900 versus reference devices.
• Error Grid and ISO Compliance: All measurements were located within Zones A and B of the Clarke and Consensus Error Grids, thereby satisfying the acceptance criteria defined by ISO 15197:2013.
• Device Consistency: Mouse-type (WH-GH23031) and stick-type (WH-G23041) models produced comparable results, confirming platform robustness.

“This pilot study showed that Glucheck provides highly accurate and precise glucose readings when a personalized algorithm setting is applied,” said Dr. Soo-Young Yoon, Principal Investigator, Korea University. “Both device models performed reliably, offering a strong, user-friendly solution for daily diabetes management.”

Context and Significance

While this study was not a regulatory trial registered with the Korean Ministry of Food and Drug Safety (MFDS), it provided a strong scientific foundation that subsequently led to Samsung’s selection of Woori IO for its C-Lab Outside program.

“Our confidence in acquiring Woori IO is firmly grounded in the strength of its clinical performance,” said Peter Hwang, CEO of OSRH. “With ISO compliance, the study’s results validate Woori IO’s core NIRS-based biosensing technology and reinforce our optimism for a clear path toward regulatory approval and commercialization.”

Next Steps: From Proof-of-Concept to Clinical Validation

Noninvasive continuous glucose monitoring (NIGM) technologies rely on solid datasets from early proof-of-concept studies such as this one, which form the empirical foundation for algorithmic refinement and device optimization. While the 2023 pilot study was not designed to continuously track glucose trends, it demonstrated the reliability of Woori IO’s sensing platform with accuracy and reliability on par with leading commercially available minimally invasive CGMs and serves as the technical basis for subsequent PoC and regulatory trials.

Building upon these results, Woori IO and Samsung are currently conducting a new PoC study, and a formal MFDS-compliant clinical trial is planned for the first half of 2026 at a leading Seoul medical center.

About OSR Holdings, Inc.

OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSRH engages in immuno-oncology, regenerative biologics, and medical device technologies to improve global health outcomes. Learn more at www.OSR-Holdings.com.

About Woori IO Co., Ltd.

Woori IO is a South Korea-based medical device company developing noninvasive biosensing technologies for glucose monitoring and beyond. Its proprietary NIRS-based platform enables accurate, pain-free glucose tracking and is designed for integration into wearable devices. Woori IO has been recognized by Samsung Electronics for its innovation and inclusion in the C-Lab Outside program.

Media & Investor Contacts
OSR Holdings, Inc.
Investor Relations
ir@osr-holdings.com

AUCKLAND, New Zealand, Nov. 6, 2025 /PRNewswire/ — 9Spokes, a leading global data platform, today announced the launch of its new Credit Card Board feature, the latest addition to its financial technology suite of solutions.

Understanding SMB wallet share and rates without costly external research is vital. 9Spokes’ Credit Card Board addresses this by providing seamless, secure access to user-consented credit card data. It includes information from all connected cards, regardless of issuer, offering a complete view of spending habits, interest rates, repayment schedules, limits, and issuing periods.

Key features and benefits include:

• Credit Insights: Aggregates transaction history, balances, rates, and repayments for precise wallet share analysis and benchmarking.
• Comprehensive Financial Overview: SMBs get an aggregated credit summary, including transaction history, balances, rates, and repayments, to aid planning, spending tracking, and repayment management. This comprehensive view enables more effective financial planning and management.
• Open Data Connectivity: Links to global bank and issuer accounts, ensuring broad coverage and accessibility.
• White-Labeled Enhanced Security: Configurable solution meets organizational needs while maintaining top-tier data protection for sensitive information and systems.

“Financial service providers gain a competitive edge with 9Spokes’ new Credit Card Board. By integrating it, we empower financial service providers to deliver unmatched value to SMBs, fostering deeper relationships and growth,” said Kevin Phalen, Chairman of 9Spokes. 

About 9Spokes

9Spokes is a global data platform that supports financial institutions and fintech firms worldwide. By aggregating consented business data from a variety of sources, 9Spokes helps businesses harness powerful tools for better financial management and strategic decision-making, driving transformation within the financial sector.